<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the five leading causes of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanisms of pathogen clearance, <z:mp ids='MP_0001845'>inflammation</z:mp> and regulation by T cells in the healthy bowel are also important in controlling <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The majority of studies analyzing T cells and their relationship to <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> growth have focused on individual T cell markers or gene clusters and thus the complexity of the T cell response contributing to the growth of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is not clear </plain></SENT>
<SENT sid="3" pm="."><plain>We have studied the T cells in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and have defined a unique T cell signature for <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> tissue </plain></SENT>
<SENT sid="4" pm="."><plain>Using a novel analytical flow cytometric approach in concert with confocal microscopy, we have shown that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> has a lower frequency of effector T cells (CD69+), but a higher frequency of both regulatory (CD25hi Foxp3+) and inflammatory T cells (IL-17+) compared with associated nontransformed bowel tissue </plain></SENT>
<SENT sid="5" pm="."><plain>We have also identified minor populations of T cells expressing conventional markers of both inflammatory and regulatory T cells (CD4+IL-17+Foxp3+) in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue </plain></SENT>
<SENT sid="6" pm="."><plain>These cells may represent intermediate populations or they may dictate an inflammatory versus regulatory function in surrounding T cells </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these data describe an immune microenvironment in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> unique to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue and distinct from the surrounding healthy bowel tissue, and this distinct environment is reflected by a gradient of T cells expressing markers of multiple T cell populations </plain></SENT>
<SENT sid="8" pm="."><plain>These findings may be used to improve diagnosis and prognosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>